Varaico: Literature-Extracted Genetic Variants

Gene:PRSS1
Variant:p.D19A
Back to variants list

PRSS1

NM_002769.5:p.D19A

Associated Papers

Pathologically relevant trypsinogen activation in pancreatitis.

Geisz-Fremy A

American Journal of Physiology. Gastrointestinal and Liver Physiology, 2026

Frequency of de novo PRSS1 pathogenic variants in a French cohort of idiopathic pancreatitis.

Masson E et al.

Gut, 2025

A Case Report on Protease Serine 1 (PRSS1)-Related Acute Pancreatitis.

Vijayakumar V et al.

Cureus, 2025

Genetics and Genomics of Chronic Pancreatitis with a Focus on Disease Biology and Molecular Pathogenesis.

Khan E et al.

Global Medical Genetics, 2023

Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN study group.

Masson E et al.

Pancreatology : Official Journal of the International Association of Pancreatology (iap) ... [et Al.], 2023

Expanding ACMG variant classification guidelines into a general framework.

Masson E et al.

Human Genomics, 2022

Hereditary Pancreatitis-25 Years of an Evolving Paradigm: Frank Brooks Memorial Lecture 2021.

Sahin-Tóth M

Pancreas, 2022

Evolutionary expansion of polyaspartate motif in the activation peptide of mouse cationic trypsinogen limits autoactivation and protects against pancreatitis.

Orekhova A et al.

American Journal of Physiology. Gastrointestinal and Liver Physiology, 2021

Genetic Risk Factors in Early-Onset Nonalcoholic Chronic Pancreatitis: An Update.

Wertheim-Tysarowska K et al.

Genes, 2021

Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B.

Demcsák A et al.

Scientific Reports, 2019

Genetics, Cell Biology, and Pathophysiology of Pancreatitis.

Mayerle J et al.

Gastroenterology, 2019

Novel Pathogenic PRSS1 Variant p.Glu190Lys in a Case of Chronic Pancreatitis.

Jancsó Z et al.

Frontiers in Genetics, 2019

A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation.

Geisz A et al.

Nature Communications, 2018

Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway.

Hegyi E et al.

Digestive Diseases and Sciences, 2017

Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis.

Németh BC et al.

American Journal of Physiology. Gastrointestinal and Liver Physiology, 2014

Pancreatic cancer risk in hereditary pancreatitis.

Weiss FU

Frontiers in Physiology, 2014

Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.

Geisz A et al.

The Febs Journal, 2013

Genetics and pathogenesis of chronic pancreatitis: the 2012 update.

Chen JM et al.

Clinics and Research in Hepatology and Gastroenterology, 2012

An overview of hereditary pancreatitis.

Rebours V et al.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2012

Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis.

Joergensen MT et al.

Pancreas, 2011

Genetic factors in chronic pancreatitis; implications for diagnosis, management and prognosis.

Derikx MH et al.

Best Practice & Research. Clinical Gastroenterology, 2010

Uncertainties in the classification of human cationic trypsinogen (PRSS1) variants as hereditary pancreatitis-associated mutations.

Szmola R et al.

Journal of Medical Genetics, 2010

Intracellular autoactivation of human cationic trypsinogen mutants causes reduced trypsinogen secretion and acinar cell death.

Kereszturi E et al.

The Journal of Biological Chemistry, 2009

Hereditary pancreatitis caused by a double gain-of-function trypsinogen mutation.

Masson E et al.

Human Genetics, 2008

Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis.

Masson E et al.

Human Genetics, 2008

Trypsinogen copy number mutations in patients with idiopathic chronic pancreatitis.

Masson E et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 2008

Histopathological features of patients with chronic pancreatitis due to mutations in the PRSS1 gene: evaluation of BRAF and KRAS2 mutations.

Felderbauer P et al.

Digestion, 2008

Copy number variations in chronic pancreatitis.

Chen JM et al.

Cytogenetic and Genome Research, 2008

Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene.

Boulling A et al.

European Journal of Human Genetics : Ejhg, 2007

Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.

Räty S et al.

Scandinavian Journal of Gastroenterology, 2007

Detection of a large genomic deletion in the pancreatic secretory trypsin inhibitor (SPINK1) gene.

Masson E et al.

European Journal of Human Genetics : Ejhg, 2006

Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis.

Teich N et al.

Human Mutation, 2006

Trypsinogen mutations in pancreatic disorders.

Vitone LJ et al.

Endocrinology and Metabolism Clinics of North America, 2006

The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.

Nemoda Z et al.

The Journal of Biological Chemistry, 2005

Gene conversion between functional trypsinogen genes PRSS1 and PRSS2 associated with chronic pancreatitis in a six-year-old girl.

Teich N et al.

Human Mutation, 2005

Genetics of pancreatitis.

Keim V

Scandinavian Journal of Surgery : Sjs : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 2005

Cationic trypsinogen mutations and pancreatitis.

Howes N et al.

Gastroenterology Clinics of North America, 2004

[Hereditary pancreatitis].

Nishimori I et al.

Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine, 2004

Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).

Teich N et al.

Human Mutation, 2004

Evolution of trypsinogen activation peptides.

Chen JM et al.

Molecular Biology and Evolution, 2003

[Frequency of CFTR gene mutations in idiopathic pancreatitis].

Maire F et al.

Gastroenterologie Clinique Et Biologique, 2003

[A case of chronic pancreatitis in a young woman with the cationic trypsinogen (PRSS1) gene mutation].

Kakinoki K et al.

Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-enterology, 2002

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."